INCB-8696

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameINCB-8696
Drug Alias NameINCB-8696
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-C chemokine receptor type 2 antagonists
TargetsC-C chemokine receptor type 2
Therapy Area/IndicationsLupus NephritisMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIncyte Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIncyte Corp
Active IndicationsN/A
Inactive IndicationsLupus NephritisMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A